Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
SHH: 603811.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Chunjian Zhao
- Employees
- 738
- Headquarters
- Wenzhou, China
- IPO year
- 2017
- Market cap
- CN¥4.0B
- Website
- https://www.chengyipharma.com
Loading 603811…
Loading profile data…Frequently asked questions about 603811
What does Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS) do?
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. produces and sells APIs and capsules/tablets in China. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was founded in 1966 and is headquartered in Wenzhou,...
Where does 603811.SS trade?
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS) trades on the Shanghai Stock Exchange.
What sector is 603811.SS in?
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Zhejiang Cheng Yi Pharmaceutical Co., Ltd.?
Chunjian Zhao is the chief executive officer of Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS).
Where is Zhejiang Cheng Yi Pharmaceutical Co., Ltd. headquartered?
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. is headquartered in China.
Does 603811.SS pay a dividend?
Yes — Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS) paid a trailing twelve-month dividend of CNY 0.25 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 603811.SS go public?
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (603811.SS) completed its initial public offering in 2017.